HSA — authorised 29 December 1989
- Marketing authorisation holder: BRACCO
- Status: likely_approved
HSA authorised Rubidium Chloride Rb 82 on 29 December 1989
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 29 December 1989.
BRACCO holds the Singaporean marketing authorisation.